
|Articles|February 23, 2011
National Comprehensive Cancer Network Guideline Updates From the 15th Annual Congress
Advertisement
Credits: 1.0 contact hours (0.10 CEUs)
Anthony Elias, MD, Professor of Medicine, Medical Director, Breast Cancer and Sarcoma Programs, University of Colorado Cancer Center
Educational Objectives
After completing this activity, participants should be able to:
- List some of the major National Comprehensive Cancer Network (NCCN) practice guideline revisions presented at the 15th Annual Congress
- Identify select NCCN guideline revisions that may impact the course of treatment in a given case
- Discuss the use of patient characteristics to determine therapeutic management in select NCCN guideline revisions
Target Audience: Pharmacy directors/administrators, clinical pharmacists practicing in managed care environments, and any other pharmacist practitioners involved in the care of patients diagnosed with cancer.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access
5




